FR2011M - Médicament nouveau a base de n-arylsulfonyl-n'-(1,2,3,6-tétrahydro-1-pyridyl)-urées. - Google Patents

Médicament nouveau a base de n-arylsulfonyl-n'-(1,2,3,6-tétrahydro-1-pyridyl)-urées.

Info

Publication number
FR2011M
FR2011M FR910922A FR910922A FR2011M FR 2011 M FR2011 M FR 2011M FR 910922 A FR910922 A FR 910922A FR 910922 A FR910922 A FR 910922A FR 2011 M FR2011 M FR 2011M
Authority
FR
France
Prior art keywords
arylsulfonyl
ureas
tetrahydro
pyridyl
new drug
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR910922A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmacia and Upjohn Co
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Priority to FR910922A priority Critical patent/FR2011M/fr
Application granted granted Critical
Publication of FR2011M publication Critical patent/FR2011M/fr
Active legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/70Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/92Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with a hetero atom directly attached to the ring nitrogen atom
    • C07D211/98Nitrogen atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
FR910922A 1961-07-03 1962-10-01 Médicament nouveau a base de n-arylsulfonyl-n'-(1,2,3,6-tétrahydro-1-pyridyl)-urées. Active FR2011M (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR910922A FR2011M (fr) 1961-07-03 1962-10-01 Médicament nouveau a base de n-arylsulfonyl-n'-(1,2,3,6-tétrahydro-1-pyridyl)-urées.

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US121329A US3105006A (en) 1961-07-03 1961-07-03 Novel nu-arylsulfonyl-nu'-(1, 2, 3, 6-tetrahydro-1-pyridyl) ureas and oral antidiabetic compositions
FR902714A FR1500755A (fr) 1961-07-03 1962-07-02 N-arylsulfonyl-n'-(1, 2, 3, 6-tétrahydro-1-pyridyl) urées et leur procédé de fabrication
FR910922A FR2011M (fr) 1961-07-03 1962-10-01 Médicament nouveau a base de n-arylsulfonyl-n'-(1,2,3,6-tétrahydro-1-pyridyl)-urées.

Publications (1)

Publication Number Publication Date
FR2011M true FR2011M (fr) 1963-09-09

Family

ID=22395977

Family Applications (2)

Application Number Title Priority Date Filing Date
FR902714A Expired FR1500755A (fr) 1961-07-03 1962-07-02 N-arylsulfonyl-n'-(1, 2, 3, 6-tétrahydro-1-pyridyl) urées et leur procédé de fabrication
FR910922A Active FR2011M (fr) 1961-07-03 1962-10-01 Médicament nouveau a base de n-arylsulfonyl-n'-(1,2,3,6-tétrahydro-1-pyridyl)-urées.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
FR902714A Expired FR1500755A (fr) 1961-07-03 1962-07-02 N-arylsulfonyl-n'-(1, 2, 3, 6-tétrahydro-1-pyridyl) urées et leur procédé de fabrication

Country Status (7)

Country Link
US (1) US3105006A (fr)
BE (1) BE619644A (fr)
BR (1) BR6239923D0 (fr)
DK (1) DK104788C (fr)
FR (2) FR1500755A (fr)
GB (1) GB983370A (fr)
SE (1) SE317073B (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3542768A (en) * 1964-12-18 1970-11-24 Geigy Chem Corp N - arylsulfonyl urea derivatives of nitrogen containing heterocyclics
US3384643A (en) * 1965-02-17 1968-05-21 Upjohn Co 1-hydrocarbylsulfonyl-2, 2-dichloro (ordialkoxy)-4, 5-imidazolidine diones
US3699226A (en) * 1970-03-02 1972-10-17 Ciba Geigy Corp N-arylsulfonyl urea derivatives of nitrogen containing heterocyclics as hypoglycemic agents
EP1151993A4 (fr) * 1999-02-08 2002-04-10 Shionogi & Co Derives d'amine cyclique et leurs utilisations

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2947756A (en) * 1960-08-02 Process for preparation of
GB789702A (en) * 1954-11-05 1958-01-29 Hercules Powder Co Ltd Improvements in or relating to preparation of nitrosamines
US2953570A (en) * 1957-06-13 1960-09-20 Grace W R & Co Method of making hydrazine derivatives
US2909525A (en) * 1957-08-08 1959-10-20 Warner Lambert Pharmaceutical Anti-fungal compounds
US2928871A (en) * 1957-10-01 1960-03-15 Hoffmann La Roche 1-terpenyl-3-arylsulfonylureas
US2974166A (en) * 1959-09-15 1961-03-07 Hoffmann La Roche Certain 1-arylsulfonyl-3-(cis-2-decalyl)ureas

Also Published As

Publication number Publication date
FR1500755A (fr) 1967-11-10
DK104788C (da) 1966-07-04
SE317073B (fr) 1969-11-10
GB983370A (en) 1965-02-17
BR6239923D0 (pt) 1973-05-24
US3105006A (en) 1963-09-24
BE619644A (fr) 1963-01-02

Similar Documents

Publication Publication Date Title
FR1538M (fr) Médicaments a base de pipérazine.
FR2669M (fr) Nouvelles 1,2,4-triazolones-(5).
FR1038M (fr) Médicament a base d'aspirine.
FR3464M (fr) Médicament agissant sur le systeme nerveux central a base d'azaspiranes.
FR2186M (fr) Médicament a base d'un dérivé de l'aniline.
FR2011M (fr) Médicament nouveau a base de n-arylsulfonyl-n'-(1,2,3,6-tétrahydro-1-pyridyl)-urées.
FR3405M (fr) Médicament a base d'une sulfométhyl-polymyxine.
FR1549M (fr) Nouveau médicament vasodilatateur a base de pipérazine disubstituée.
FR2288M (fr) Médicament analgésique et anti-émétique, a base de 1-phényl-3-(beta-diéthylamino-éthyl)-imidazolidones-(2).
FR1827M (fr) Médicament a base de 1.5-benzo-dioxépannes.
FR2239M (fr) Médicaments a base de dialcoyl-aminoalcoyl-pipéridines.
FR2231M (fr) Médicament a base de nouvelles dibenzothiéphinnes.
FR1393M (fr) Médicament a base de sulfonyl-urées.
FR2415M (fr) Médicament a base d'éthanolamines substituées.
FR3452M (fr) Composés thérapeutiques a base de nouvelles 1,4-benzodiazépines substituées.
FR2721M (fr) Médicament a base de dicarbamates d'haloalkyl-1,3-propanediols.
FR2220M (fr) Médicament sédatif a base de dérivé de carbamate d'aryloxy-alcoyle.
FR3774M (fr) Médicament a base de nouvelles oxaza-bicyclo-alcanones.
FR3565M (fr) Médicament a base d'un nonapeptide-amide cyclique.
FR3378M (fr) Médicaments a base de (4-phénoxy-3,5-diiodophényl)-alcanols.
FR1987M (fr) Médicament antilipémique a base d'héparine modifiée.
FR2992M (fr) Médicament a base de 2.4-diamino-6-hydroxyméthyl-7.8-dihydro-ptéridine.
FR1864M (fr) Médicament nouveau a base de mercapto-acyl-amido-5-nitrothiazoles.
FR2577M (fr) Médicament a base de naphtyl-amino-imidazoline.
FR2925M (fr) Médicament a base de nouvelles sulfapyrimidines.